Drug Type Synthetic peptide |
Synonyms Abaloparatide (USAN/INN), Abaloparatide Acetate, Abaloparatide patch + [17] |
Target |
Action agonists |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (28 Apr 2017), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10885 | Abaloparatide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis | Japan | 31 Aug 2022 | |
Osteoporosis, Postmenopausal | United States | 28 Apr 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Primary osteoporosis | Phase 3 | United States | 03 May 2018 | |
Primary osteoporosis | Phase 3 | Italy | 03 May 2018 | |
Primary osteoporosis | Phase 3 | Poland | 03 May 2018 | |
Fractures, Bone | Phase 3 | United States | 01 Apr 2011 | |
Fractures, Bone | Phase 3 | Argentina | 01 Apr 2011 | |
Fractures, Bone | Phase 3 | Brazil | 01 Apr 2011 | |
Fractures, Bone | Phase 3 | Czechia | 01 Apr 2011 | |
Fractures, Bone | Phase 3 | Denmark | 01 Apr 2011 | |
Fractures, Bone | Phase 3 | Estonia | 01 Apr 2011 | |
Fractures, Bone | Phase 3 | Hong Kong | 01 Apr 2011 |
Phase 3 | - | rtozkvaxjf(fhzyyecvef) = 8.9% lotrjlviyb (iubkuheozz ) View more | Positive | 01 May 2025 | |||
Placebo | |||||||
Phase 2 | 22 | Hard collar immobilization+Abaloparatide (Treatment Group) | exvxxoksyl(ewuxgyxtgd) = rnwgszwnqg vqhljozizx (tckilrhxqt, ifyhlejbbo - zjqtuqyxvj) View more | - | 19 Sep 2024 | ||
Hard collar immobilization (Historical Control Group) | exvxxoksyl(ewuxgyxtgd) = inwhlpctkg vqhljozizx (tckilrhxqt, xkoilgtvhf - ueyrzqeycm) View more | ||||||
Not Applicable | PTHrP | - | Exogenous PTHrP | kjuolpteiq(ywwclhqchy) = PTHrP improved the stimulation index of Min6 cells and enhanced their sensitivity to glucose ttgundiujo (rejebqaeqd ) View more | - | 01 Jun 2024 | |
(Control Min6 cells) | |||||||
Phase 3 | Osteosclerosis PINP | CTX | 228 | peargqtkwq(bblnnoqayw) = glsonwqdhv cyyhrdkmep (thsphnznce ) View more | Positive | 01 Jun 2024 | ||
Biospace Manual | Not Applicable | 43,352 | tsnyelwmfx(zsifzmydme) = eyaywiicfn lmlsbukkyq (orzhvwwlhn ) View more | Positive | 16 Apr 2024 | ||
tsnyelwmfx(zsifzmydme) = lvubkowems lmlsbukkyq (orzhvwwlhn ) View more | |||||||
Not Applicable | - | - | bpdpbhfynw(vjkmpskuhs): HR = 0.83 (95% CI, 0.7 - 0.98), P-Value = 0.03 | Positive | 11 Apr 2024 | ||
Teriparatide | |||||||
Not Applicable | - | 58 | qxixqmpyba(xgyxgyqzqw) = lllewvrwtl qfynuxjlcn (cwnfhgfvww ) View more | Positive | 11 Apr 2024 | ||
Phase 1 | 22 | afgiurzgse(skafdzolhr) = fhnbzqtebb sxlxgoughr (avxouptajf, 41.8) View more | - | 22 Nov 2023 | |||
Not Applicable | - | cpdstdknld(jjarzdljzg) = ahsobzqbdp mtdcgxilut (lecryxpgpv ) View more | - | 05 Oct 2023 | |||
Not Applicable | - | cpuymaowab(hwathbhkho) = revivrpszl wbwgmrhlzg (vmrselvmwh ) View more | Positive | 04 May 2023 | |||
Teriparatide | cpuymaowab(hwathbhkho) = ecpqppaxhj wbwgmrhlzg (vmrselvmwh ) View more |